Avenue Therapeutics Inc (ATXI)
1.88
-0.07
(-3.59%)
USD |
NASDAQ |
Nov 14, 16:00
1.88
0.00 (0.00%)
After-Hours: 17:29
Avenue Therapeutics Enterprise Value: -3.065M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -3.065M |
| November 12, 2024 | -2.943M |
| November 11, 2024 | -2.993M |
| November 08, 2024 | -2.721M |
| November 07, 2024 | -2.578M |
| November 06, 2024 | -2.650M |
| November 05, 2024 | -2.678M |
| November 04, 2024 | -2.707M |
| November 01, 2024 | -2.650M |
| October 31, 2024 | -2.421M |
| October 30, 2024 | -2.421M |
| October 29, 2024 | -2.349M |
| October 28, 2024 | -2.249M |
| October 25, 2024 | -2.707M |
| October 24, 2024 | -2.965M |
| October 23, 2024 | -2.850M |
| October 22, 2024 | -2.836M |
| October 21, 2024 | -2.993M |
| October 18, 2024 | -2.836M |
| October 17, 2024 | -3.008M |
| October 16, 2024 | -2.821M |
| October 15, 2024 | -2.864M |
| October 14, 2024 | -2.957M |
| October 11, 2024 | -2.907M |
| October 10, 2024 | -2.965M |
| Date | Value |
|---|---|
| October 09, 2024 | -3.022M |
| October 08, 2024 | -3.036M |
| October 07, 2024 | -3.022M |
| October 04, 2024 | -2.886M |
| October 03, 2024 | -2.535M |
| October 02, 2024 | -2.392M |
| October 01, 2024 | -2.421M |
| September 30, 2024 | -2.292M |
| September 27, 2024 | -2.263M |
| September 26, 2024 | -2.499M |
| September 25, 2024 | -2.650M |
| September 24, 2024 | -2.635M |
| September 23, 2024 | -2.435M |
| September 20, 2024 | -2.335M |
| September 19, 2024 | -2.12M |
| September 18, 2024 | -1.991M |
| September 17, 2024 | -1.905M |
| September 16, 2024 | -1.862M |
| September 13, 2024 | -1.834M |
| September 12, 2024 | -1.848M |
| September 11, 2024 | -1.705M |
| September 10, 2024 | -1.762M |
| September 09, 2024 | -1.540M |
| September 06, 2024 | -1.805M |
| September 05, 2024 | -1.848M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.065M
Minimum
Nov 13 2024
195.54M
Maximum
Sep 14 2020
42.97M
Average
8.456M
Median
Enterprise Value Benchmarks
| Fortress Biotech Inc | -1.023M |
| Checkpoint Therapeutics Inc | 157.56M |
| Journey Medical Corp | 102.58M |
| NovaBay Pharmaceuticals Inc | 3.432M |
| Palatin Technologies Inc | 13.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.186M |
| Total Expenses (Quarterly) | 2.823M |
| EPS Diluted (Quarterly) | -6.43 |
| Earnings Yield | -822.1% |